AVXL R&D Expenses
Anavex Life Sciences Corp · R&D Expenses
AVXL R&D Expenses
Latest reported$20.29Mperiod ending
AVXL R&D Expenses ($0.00 → $20.29M)
Annual R&D Expenses
High-resolution chart · PNG
AVXL r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 37,592,000 | |
| 41,838,000 | |
| 43,717,000 | |
| 37,916,000 | |
| 32,984,000 | |
| 25,231,623 | |
| 22,260,349 | |
| 13,344,421 | |
| 10,672,086 | |
| 7,254,303 | |
| 2,271,736 | |
| 732,395 | |
| 263,847 | |
| 2,653,860 | |
| 2,597,279 | |
| 2,728,836 | |
| 2,139,794 | |
| 1,479,482 | |
| 959,698 | |
| 0 | |
| 0 | |
| 0 |